Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online October 24, 2007
Diabetes 57:269-275, 2008
DOI: 10.2337/db07-1095
© 2008 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow All Versions of this Article:
db07-1095v1
57/1/269    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gysemans, C.
Right arrow Articles by Mathieu, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gysemans, C.
Right arrow Articles by Mathieu, C.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Brief Report

Unaltered Diabetes Presentation in NOD Mice Lacking the Vitamin D Receptor

Conny Gysemans1, Evelyne van Etten1, Lutgart Overbergh1, Annapaula Giulietti1, Guy Eelen1, Mark Waer2, Annemieke Verstuyf1, Roger Bouillon1, and Chantal Mathieu1

1 Laboratory of Experimental Medicine and Endocrinology, Department of Experimental Medicine, Katholieke Universiteit Leuven, Leuven, Belgium
2 Laboratory of Experimental Transplantation, Department of Experimental Medicine, Katholieke Universiteit Leuven, Leuven, Belgium

Address correspondence and reprint requests to Chantal Mathieu, MD, PhD, LEGENDO, Campus Gasthuisberg O&N1, Katholieke Universiteit Leuven, Herestraat 49, 3000 Leuven, Belgium. E-mail: chantal.mathieu{at}med.kuleuven.be

Key Words: AUC, area under the curve • 1,25-dihydroxyvitamin D3, 1,25(OH)2D3 • CCL2, CC chemokine ligand 2 • IL, interleukin • LPS, lipopolysaccharide • NF-{kappa}B, nuclear factor-{kappa}B • VDR, vitamin D receptor

OBJECTIVE— Vitamin D deficiency increases risk for type 1 diabetes in genetically predisposed individuals, while high doses of 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] prevent insulitis and diabetes in NOD mice.

RESEARCH DESIGN AND METHODS— Since 1,25(OH)2D3 regulates gene transcription through the vitamin D receptor (VDR), we investigated the role of VDR in diabetes development by creating NOD mice without functional VDR.

RESULTS— VDR–/– NOD mice are rachitic and have lower numbers of putative regulator cells [TCR-{alpha}+CD4CD8 (natural killer T-cells) and CD4+CD25+ T-cells [in central and peripheral immune organs compared with VDR+/+ NOD littermates. Lipopolysaccharide-stimulated VDR–/– NOD macrophages expressed lower interleukin (IL)-1, IL-6, and CC chemokine ligand 2 mRNA, correlating with less nuclear translocation of p65 nuclear factor-{kappa}B compared with VDR+/+ NOD macrophages. Thymic and lymph node dendritic cells from VDR–/– NOD mice displayed an even less mature CD11c+CD86+ phenotype than VDR+/+ NOD mice. Despite this immune phenotype linked to diabetes in NOD mice, VDR–/– NOD mice developed insulitis and diabetes at the same rate and incidence as VDR+/+ NOD littermates.

CONCLUSIONS— Despite aggravating known immune abnormalities in NOD mice, disruption of VDR does not alter disease presentation in NOD mice in contrast to the more aggressive diabetes presentation in vitamin D–deficient NOD mice.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.